Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.

ARTL Insider Trading

Insider Ownership Percentage: 3.51%
Insider Buying (Last 12 Months): $4,836.00
Insider Selling (Last 12 Months): $0.00

Artelo Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Artelo Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Artelo Biosciences Share Price & Price History

Current Price: $3.20
Price Change: Price Decrease of -0.01 (-0.31%)
As of 01/27/2023 01:00 AM ET

This chart shows the closing price history over time for ARTL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.

Artelo Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2022Gregory D. GorgasCEOBuy1,200$4.03$4,836.001,200View SEC Filing Icon  
4/16/2021Gregory D. GorgasCEOBuy8,500$1.15$9,775.00270,676View SEC Filing Icon  
5/15/2020Gregory D. GorgasCEOBuy4,200$1.22$5,124.00
5/4/2020Connie MatsuiDirectorBuy41,667$1.27$52,917.09
5/4/2020Gregory D. GorgasCEOBuy4,167$1.27$5,292.09
See Full Table
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.

SEC Filings (Institutional Ownership Changes) for Artelo Biosciences (NASDAQ:ARTL)

4.72% of Artelo Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARTL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Artelo Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Two Sigma Advisers LP35,062$0.12M0.0%N/A1.228%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP10,608$37K0.0%N/A0.371%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.71,038$0.25M0.0%-89.6%2.487%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC182,619$82K0.0%+67.8%0.432%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.683,896$0.31M0.0%-23.2%1.617%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC22,594$27K0.0%-85.3%0.092%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC556,738$0.66M0.0%N/A2.273%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.862,172$1.03M0.0%+247.5%3.520%Search for SEC Filing on Google Icon
8/12/2021Penserra Capital Management LLC28,427$27K0.0%N/A0.116%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp86,603$0.10M0.0%-15.4%0.354%Search for SEC Filing on Google Icon
8/6/2021HighTower Advisors LLC62,000$74K0.0%N/A0.253%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC153,769$0.25M0.0%N/A0.664%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC180,814$0.30M0.0%N/A0.781%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC21,108$34K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/13/2021Kepos Capital LP200,000$0.33M0.0%-20.0%0.864%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp102,390$0.17M0.0%N/A0.442%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC141,273$0.23M0.0%+132.1%0.610%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG15,675$26K0.0%N/A0.068%Search for SEC Filing on Google Icon
4/6/2021LVM Capital Management Ltd. MI20,000$33K0.0%N/A0.127%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Artelo Biosciences logo
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA.
Read More on Artelo Biosciences

Today's Range

Now: $3.20
Low: $3.14
High: $3.22

50 Day Range

MA: $2.91
Low: $2.40
High: $3.41

52 Week Range

Now: $3.20
Low: $2.38
High: $11.07

Volume

7,641 shs

Average Volume

22,955 shs

Market Capitalization

$9.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Artelo Biosciences?

Artelo Biosciences' top insider shareholders include:
  1. Gregory D Gorgas (CEO)
Learn More about top insider investors at Artelo Biosciences.
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.